Source:http://linkedlifedata.com/resource/pubmed/id/15922087
Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
1-2
|
pubmed:dateCreated |
2005-5-30
|
pubmed:abstractText |
We analyzed the effect of molecular iodine (I2), potassium iodide (KI) and a subclinical concentration of thyroxine (T4) on the induction and promotion of mammary cancer induced by N-methyl-N-nitrosourea. Virgin Sprague-Dawley rats received short or continuous treatment. Continuous I2 treated rats exhibited a strong and persistent reduction in mammary cancer incidence (30%) compared to controls (72.7%). Interruption of short or long term treatments resulted in a higher incidence in mammary cancer compared to the control groups. The protective effect of I2 was correlated with the highest expression of the I-/Cl- transporter pendrin and with the lowest levels of lipoperoxidation expression in mammary glands. Triiodothyronine serum levels and Na+/I- symporter, lactoperoxidase, or p53 expression did not show any changes. In conclusion continuous I2 treatment has a potent antineoplastic effect on the progression of mammary cancer and its effect may be related to a decrease in the oxidative cell environment.
|
pubmed:commentsCorrections | |
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical |
http://linkedlifedata.com/resource/pubmed/chemical/Antineoplastic Agents,
http://linkedlifedata.com/resource/pubmed/chemical/Chloride-Bicarbonate Antiporters,
http://linkedlifedata.com/resource/pubmed/chemical/Iodides,
http://linkedlifedata.com/resource/pubmed/chemical/Iodine,
http://linkedlifedata.com/resource/pubmed/chemical/Methylnitrosourea,
http://linkedlifedata.com/resource/pubmed/chemical/Thyroxine,
http://linkedlifedata.com/resource/pubmed/chemical/pendrin protein, rat
|
pubmed:status |
MEDLINE
|
pubmed:month |
May
|
pubmed:issn |
0303-7207
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:day |
31
|
pubmed:volume |
236
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
49-57
|
pubmed:dateRevised |
2006-11-15
|
pubmed:meshHeading |
pubmed-meshheading:15922087-Animals,
pubmed-meshheading:15922087-Antineoplastic Agents,
pubmed-meshheading:15922087-Chloride-Bicarbonate Antiporters,
pubmed-meshheading:15922087-Female,
pubmed-meshheading:15922087-Incidence,
pubmed-meshheading:15922087-Iodides,
pubmed-meshheading:15922087-Iodine,
pubmed-meshheading:15922087-Lipid Peroxidation,
pubmed-meshheading:15922087-Mammary Neoplasms, Experimental,
pubmed-meshheading:15922087-Methylnitrosourea,
pubmed-meshheading:15922087-Oxidation-Reduction,
pubmed-meshheading:15922087-Rats,
pubmed-meshheading:15922087-Rats, Sprague-Dawley,
pubmed-meshheading:15922087-Thyroxine,
pubmed-meshheading:15922087-Up-Regulation
|
pubmed:year |
2005
|
pubmed:articleTitle |
Inhibition of N-methyl-N-nitrosourea-induced mammary carcinogenesis by molecular iodine (I2) but not by iodide (I-) treatment Evidence that I2 prevents cancer promotion.
|
pubmed:affiliation |
Instituto de Neurobiología, Universidad Nacional Autónoma de México, Km 15 Carretera Qro-SLP, Juriquilla, Querétaro 76230, Mexico.
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't
|